EP2846791
HPN-100 til notkunar við meðhöndlun á blóðnituraukningu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.9.2012EP published:
8.2.2017EP application number:
12874745.8
EP translation filed:
20.3.2017Grant published:
15.4.2017EPO information:
European Patent Register
Max expiry date:
10.9.2032Expiry date:
10.9.2026Next due date:
30.9.2026
Title:
HPN-100 FOR USE IN THE TREATMENT OF NITROGEN RETENTION DISORDERS
Timeline
Today
11.9.2012EP application
8.2.2017EP Publication
20.3.2017Translation submitted
15.4.2017Registration published
10.9.2026Expires
Owner
Name:
Immedica Pharma ABAddress:
Norrtullsgatan 15, 113 29, Stockholm, , SE
Inventor
Name:
SCHARSCHMIDT, BruceAddress:
San Francisco, California, US
Name:
MOKHTARANI, MasoudAddress:
Walnut Creek, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261636256 PDate:
20.4.2012Country:
US
Classification
Categories:
A61K 31/216, A61K 31/185, A61P 1/16, A61P 13/12, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.8.2017
Expires: 10.9.2018
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 20.8.2018
Expires: 10.9.2019
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.8.2019
Expires: 10.9.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 9
Paid: 20.8.2020
Expires: 10.9.2021
Payer: Zacco Denmark A/S
Number: 10
Paid: 4.8.2021
Expires: 10.9.2022
Payer: Zacco Denmark A/S
Number: 11
Paid: 8.8.2022
Expires: 10.9.2023
Payer: Zacco Denmark A/S
Number: 12
Paid: 8.8.2023
Expires: 10.9.2024
Payer: Zacco Denmark A/S
Number: 13
Paid: 26.8.2024
Expires: 10.9.2025
Payer: Zacco Denmark A/S
Number: 14
Paid: 28.8.2025
Expires: 10.9.2026
Payer: Zacco Denmark A/S